Aquatic Animal Health Research Site Logo
ARS Home About Us Helptop nav spacerContact Us En Espanoltop nav spacer
Printable VersionPrintable Version     E-mail this pageE-mail this page
Agricultural Research Service United States Department of Agriculture
Search
  Advanced Search
Programs and Projects
Subjects of Investigation
 

Research Project: NUTRITION, IMMUNE SYSTEM ENHANCEMENT, AND PHYSIOLOGY OF AQUATIC ANIMALS

Location: Aquatic Animal Health Research

Title: Tilapia Vaccines: Important Disease Prevention, Biosecurity Tools

Authors

Submitted to: Global Aquaculture Advocate
Publication Type: Peer Reviewed Journal
Publication Acceptance Date: March 16, 2007
Publication Date: May 1, 2007
Citation: Klesius, P.H., Shoemaker, C.A., Evans, J.J. 2007. Tilapia Vaccines: Important Disease Prevention, Biosecurity Tools. Global Aquaculture Advocate May/June page 76, 78.

Interpretive Summary: Minimizing the effects of disease is crucial to prevent mortality, morbidity and to promote rapid growth and optimal feed conversion of tilapia cultured in fresh, estuarine and marine waters. Vaccination, a valuable biosecurity safeguard, can protect tilapia against infectious diseases. Vaccination provides pathogen-specific acquired immunity that can prevent recurring infections. The high feed conversion, fast growth, high reproduction and ease of production makes Nile tilapia one of most widely cultured fish species in the world. In contrast to what was believed during the early years of intense culture, the Nile tilapia is highly susceptible to disease. Thus the profit to the producers and the consumers product costs are affected. The demands of the consumers, environmental and government groups for wholesome tilapia products and for an environment free of potentially harmful drugs and chemicals in aquaculture have increased and will continue to grow. The tilapia industry can meet these challenges with better health management practices that include the use of vaccines to prevent diseases and increase economic predictability and profitability. Vaccines are an integral part of a health management plan. The scope of information available on vaccines for tilapia and mass delivery systems is very limited.

Technical Abstract: Minimizing the effects of disease is crucial to prevent mortality, morbidity and to promote rapid growth and optimal feed conversion of tilapia cultured in fresh, estuarine and marine waters. Vaccination, a valuable biosecurity safeguard, can protect tilapia against infectious diseases. Vaccination provides pathogen-specific acquired immunity that can prevent recurring infections.

   

 
Project Team
Lim, Chhorn
Bebak, Julie
Welker, Thomas
 
Publications
   Publications
 
Related National Programs
  Aquaculture (106)
 
 
Last Modified: 05/14/2009
ARS Home | USDA.gov | Site Map | Policies and Links 
FOIA | Accessibility Statement | Privacy Policy | Nondiscrimination Statement | Information Quality | USA.gov | White House